Ricerca avanzata

Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Minerva Cardioangiologica 2015 Ottobre;63(5) > Minerva Cardioangiologica 2015 Ottobre;63(5):441-8



Rivista sulle Malattie del Cuore e dei Vasi

Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752

Periodicità: Bimestrale

ISSN 0026-4725

Online ISSN 1827-1618


Minerva Cardioangiologica 2015 Ottobre;63(5):441-8


Innovative DES technologies from Meril

Bhatt S. 1, Gujarathi S. 1, De Benedictis M. 2

1 Meril Life Sciences, Gujarat, India;
2 Unit of Cardiology, Presidio Umberto I, Azienda Ospedaliera Ordine Mauriziano, Turin, Italy

Technological advances and rise in global urbanity have paradoxically led to an increase in the incidence of metabolic syndrome and thankfully also in diagnosis and treatment of coronary artery disease. “Necessity is the mother of invention” – remarked Plato and this statement could not have had a better place than in the field of angioplasty and stenting. Interventional cardiology still continues to remain a busy place for smart, iterative changes leading to better treatment options. This article sketches contemporary trends in coronary stent engineering borne out of unmet clinical needs ranging from novel ultra-thin strut designs marrying biodegradable polymeric drug eluting platforms to anatomically tapered stents and finally the intuitive bioresorbable vascular scaffolds which promise freedom from full metal jacket.

lingua: Inglese


inizio pagina